Although it is agreed that the burden of blindness due to different types of glaucoma is high, the problem has been that we have not had either reliable ways of detecting these diseases or straightforward ways of treating them in large populations, within prevention of blindness programmes. In the past few years, however, there have been some rapid developments which are changing our perspective.